Anticoagulants and Osteoporosis.
Salvatore Santo Signorelli1, Salvatore Scuto2, Elisa Marino3
1Department of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy. ssignore@unict.it.
International Journal of Molecular Sciences
|October 27, 2019
Summary
Heparin use may increase fracture risk, while newer direct oral anticoagulants (DOACs) appear safe for bone health. Low molecular weight heparins (LMWHs) show improved safety over traditional heparin.
Area of Science:
- Pharmacology
- Bone Metabolism
- Osteoporosis Research
Background:
- Anticoagulant agents are crucial for thromboembolic event treatment and stroke prevention.
- Concerns exist regarding the impact of anticoagulants on bone health, with varying data for different drug classes.
- Osteoporosis risk necessitates careful consideration of anticoagulant therapy effects on bone.
Purpose of the Study:
- To review the effects of anticoagulant agents on bone metabolism.
- To evaluate the impact of anticoagulants on bone mineral density (BMD) and fragility fractures.
- To compare the bone safety profiles of different anticoagulant classes.
Main Methods:
- Comprehensive literature search on MEDLINE up to March 2019.
- Inclusion of published papers and review articles on anticoagulant effects on bone.
- Analysis of data concerning bone metabolism, BMD, and fracture rates.
Main Results:
- Heparin demonstrates a detrimental effect on bone, associated with increased fracture rates.
- Low molecular weight heparins (LMWHs) appear safer for bone compared to unfractionated heparin.
- Anti-vitamin K agents (VKAs) affect bone metabolism, but BMD and fracture data remain inconsistent.
- Direct oral anticoagulants (DOACs) show no adverse effects on bone health to date.
Conclusions:
- Heparin necessitates caution in patients at risk of osteoporosis due to bone detrimental effects.
- LMWHs offer a potentially safer alternative to heparin regarding bone health.
- Further research is needed to clarify the long-term effects of VKAs on bone.
- DOACs represent a bone-safe option for anticoagulation therapy.
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.0K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.0K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Bone Disorders
5.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.0K
Venous Thrombosis III: Interprofessional Care
247
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
247
Role of Vitamins in Maintaining Bone Health
4.9K
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
4.9K
Hormones and Bone Tissue
3.6K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
3.6K

